Customize your JAMA Network experience by selecting one or more topics from the list below.
Two Original Investigations, “The Prevention of Hip Fracture With Risedronate and Ergocalciferol Plus Calcium Supplementation in Elderly Women With Alzheimer Disease: A Randomized Controlled Trial,” and “Risedronate Sodium Therapy for Prevention of Hip Fracture in Men 65 Years or Older After Stroke,” were retracted on June 3, 2016.1,2 A series of Letters3-6 were written to comment on the originally published articles and were published before the Retraction notice. This formal Correction notice is published to alert readers and remind them to not rely on the subsequently retracted articles.
Caution Advised for Readers of Letters Related to Retracted Articles. JAMA Intern Med. 2017;177(9):1400. doi:https://doi.org/10.1001/jamainternmed.2017.4594
Create a personal account or sign in to: